In this video, the first in a 6-part series, panelists discuss recent advancements in PsO management.
RX Review: Integrating New Topicals Into Scalp Psoriasis Treatment Regimens
In this video, the second in a 6-part series, panelists discuss recent advancements in PsO management.
In this video, the third in a 6-part series, panelists discuss recent advancements in PsO management.
In this video, the fourth in a 6-part series, panelists discuss recent advancements in PsO management.
In this video, the fifth in a 6-part series, panelists discuss recent advancements in PsO management.
In this video, the last in a 6-part series, panelists discuss recent advancements in PsO management.
Advertisement
Advertisement
Trending on HCPLive
1
Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D
2
Orforglipron Delivers Significant Weight Loss At Every Stage of Menopause in Phase 3 ATTAIN Trials
3
What Comes Next for Berobenatide? VESPER-3 and Phase 3 Expectations, With John Buse, MD, PhD
4
ACHIEVE-5: Orforglipron Improves Glycemic Control, Weight in T2D on Basal Insulin
5